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Objectives. Several modalities have been advocated to treat traumatic scars, including surgical techniques and laser resurfacing.
Recently, a plasma skin regeneration (PSR) system has been investigated. There are no reports on plasma treatment of mesh skin
grafted scars. The objective of our study is to evaluate the eﬀectiveness and complications of plasma treatment of mesh skin grafted
scars in Asian patients. Materials and Methods. Four Asian patients with mesh skin grafted scars were enrolled in the study. The
plasma treatments were performed at monthly intervals with PSR, using energy settings of 3 to 4J. Improvement was determined
bypatientquestionnairesandphysicianevaluationofdigitalphotographstakenpriortotreatmentandat3monthsposttreatment.
The patients were also evaluated for any side eﬀects from the treatment. Results. All patients showed more than 50% improvement.
The average pain score on a 10-point scale was 6.9 +/− 1.2SD and all patients tolerated the treatments. Temporary, localized
hypopigmentation was observed in two patients. Hyperpigmentation and worsening of scarring were not observed. Conclusions.
Plasma treatment is clinically eﬀective and is associated with minimal complications when used to treat mesh skin grafted scars in
Asian patients.
1.Introduction
Lasertreatmentofscarswasﬁrstreportedin1980susingcon-
t i n u o u sw a v ec a r b o nd i o x i d e( C O 2), argon and neodymium:
yttrium–aluminum garnet(YAG) lasers. Results were opera-
tor dependent and scar recurrence or worsening of scarring
was observed [1]. In the 1990s, high energy pulsed CO2 and
erbium:YAG (Er:YAG) lasers had become available and did
improve scars and caused fewer signiﬁcant side eﬀects [2].
However, the epidermis is signiﬁcantly damaged with use of
these lasers and this can result in potential adverse eﬀects,
includingprolongederythemaandpigmentarydisturbances,
especially in Asians [3].
The plasma skin regeneration system (PSR; Portrait,
Rhytec, Inc., Waltham, MA) is a novel device that utilizes
radiofrequency to convert nitrogen gas into a high energy
state of matter called plasma. PSR has been shown to
remove benign skin lesions with similar eﬃcacy and a lower
complication rate when compared to the CO2 laser [4].
We ﬁrst reported the eﬀectiveness of plasma treatment in
improving traumatic scarring in 2009 [5].We hypothesized
that the PSR system would be eﬀective in improving mesh
skin grafted scars, with minimal downtime and few adverse
eﬀects.
2.MaterialsandMethods
Four Asian patients with traumatic scars and Fitzpatrick skin
types III or IV were enrolled in the study (Table 1). Patients
with a history of keloid formation, prior dermabrasion or
laser treatment, or isotretinoin use within the last 6 months
were not enrolled in the study. The plasma treatments were2 Plastic Surgery International
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Figure 1: Twenty eight-year-old male, mesh skin grafted scars
on left forearm (deep burn caused by explosion, age of scar was
2 months) before (a) and after eight treatment (b). Signiﬁcant
improvement was observed.
Table 1: Patients list.
Case Age Sex Region 1st treatment from
skin grafting
Treatment
times
1 28 male forearm 2m o n t h s 8
2 53 male forearm 6m o n t h s 1
33 4 f e m a l el e g 11 months 8
4 51 male forehead 17 months 3
performed at monthly intervals, using energy settings of 3 to
4J (15 to 20msec), a single pass and no overlap. Before each
plasma treatment, seven percent lidocaine cream was applied
to the treatment site for 1 hour. Immediately after treatment,
patients were asked to rate their pain level. Pain was assessed
using a visual analog scale (VAS, 0–10). Patients were seen 1
week after each treatment and also 3 months after the last
treatment. Blinded assessments of the treatment response
were made by 2 expert plastic surgeons who examined digital
photographs taken pretreatment (baseline) and 3 months
after the last treatment. Apparent improvement of the lesion
was given a score based on the following: 0 = 0%; 1 = 1% to
25%;2 =26%to50%;3 =51%to75%;and4 =76%to100%
improvement.Adverseeﬀects,includingpigmentarychanges
and worsening of the traumatic scarring, were recorded by
the same investigator who performed the treatments. Case
2 and Case 4 completed only one and three treatments,
respectively, because they were satisﬁed with their results.
3. Results
All patients completed the study (Figures 1, 2, 3,a n d4).
Case 1 and 3 experienced signiﬁcant improvement. Case 2
and 4 experienced moderate improvement (Table 2). The
average pain score on a 10-point scale was 6.9 +/− 1.2SD
(a) (b)
Figure 2: Fifty three-year-old male, mesh skin grafted scars on
left forearm (deep ﬂame burn caused by accident, age of scar was
17 months) before (a) and after one treatments (b). Moderate
improvement was observed but hypopigmentation was occurred
and gradually improved within several months.
(a) (b)
Figure 3: Thirty four-year-old female, mesh skin grafted scars on
leftfoot(deepburncausedbyexplosion,ageofscarwas11months)
before (a) and after eight treatments (b). Signiﬁcant improvement
was observed.
and all patients tolerated the procedures. The epithelization
time after treatment was 14.7 ± 7.3 days (average ±
SD). Unfortunately, Case 2 could not come to our clinic
because they had moved away, therefore we could not follow
them regularly. Temporary and local hypopigmentation was
observed in two cases and the hypopigmentation in Case
4 gradually improved within 6 months. Hyperpigmentation
andworseningofscarringwerenotobservedasaresultofthe
procedures (Table 3).Plastic Surgery International 3
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Figure 4: Fifty one-year-old female, mesh skin grafted scars on left
foot (deep burn caused by explosion, age of scar was 11 months)
before (a) and after eight treatments (b). Moderate improvement
was observed but hypopigmentation was occurred.
Table 2: Degree of improvement (n = 4).
Worse Poor,
0–25%
Mild,
26–50%
Moderate,
51–75%
Signiﬁcant,
76–100%
0/4 0/4 0/4 2/4 2/4
Table 3: Complications (n = 4).
VAS pain score (0–10) 6.9 ± 1.2
Epithelization time (days) after plasma treatment 14.7 ± 7.3
Infections 0/4
Hyperpigmentation 0/4
Hypopigmentation 2/4
Worsening of scarring 0/4
4. Discussion
While dramatic improvement is seen when using ablative
CO2 laser resurfacing to treat facial traumatic scars, it is
operator dependent.
Moreover, the epidermis is signiﬁcantly damaged during
this process and this can be associated with serious adverse
eﬀects,particularlywhenusingthismodalitytotreatscarring
of the face. These side eﬀects include transient or prolonged
erythema, temporary and permanent hypopigmentation,
hyperpigmentation, infection, and scarring, especially in
Asians [1, 3]. Hædersdal et al. reported that the nonablative
1540nm fractional laser improved the texture of mature
burn scars, particularly in superﬁcial burn scars [6].
The plasma skin regeneration system is a novel device
that utilizes radiofrequency to convert nitrogen gas into a
high energy state of matter called plasma [7–9]. The plasma
is emitted at 5–15 millisecond pulses into the skin and can
be delivered at 1–4J of energy. Because the plasma skin
regeneration device is not a laser, its mechanism of action is
not dependent on chromophores. There is no direct means
for radiofrequency transfer into the treatment area. Rapid
heating of the skin occurs as the excited gas gives up energy
to the skin. The epidermis becomes nonviable and there is
controlled thermal modiﬁcation to the underlying dermis
with minimal thermal injury to surrounding tissues. The
zone of thermal injury is less than the CO2 laser [4].
Plasma treatment is used for skin rejuvenation. Bogle
et al. reported that with plasma skin rejuvenation, using
a multiple treatment, low-energy (1.2–1.8J) technique,
physicians can successfully improve photodamaged facial
skin with minimal downtime [7]. In Bogle’s study, re-
epithelialization was complete in 4 days and only temporary
hyperpigmentation was observed.
More recently, Gonzalez et al. reported a single high-
energy (3.5–4J) plasma treatment can signiﬁcantly improve
acne scarring [10]. Their study demonstrates that, while the
magnitude of improvement with plasma treatment is not as
dramatic as that seen with multipass CO2 laser treatment, a
high energy, double pass, PSR treatment requires minimal
operator training to achieve predictable and safe improve-
ment in acne scars.
In contrast to aggressive ablative techniques, plasma
regeneration maintains the integrity of the epidermis, which
leads to less social downtime and less risk of signiﬁcant side
eﬀects.
Inourstudy,plasmatreatmentwaseﬀectiveinimproving
mesh skin grafted scars in Asian with minimal side eﬀects.
We reported previously that the PSR is not eﬀective for
deep scars because good remodeling could not be achieved,
so wide and deep scars, such as abdominal surgery scars, are
not good candidates for plasma treatment [5].
Hyperpigmented scars were improved in color after
plasmatreatmentandtheriskofadverseeﬀectswasminimal,
even in dark skin patients [5]. In this study, one patient
developed hypopigmentation after plasma treatment with
4J. This improved over a 6-month period.
In contrast to the CO2 laser, plasma treatment maintains
the integrity of the epidermis, leading to low risk of scar
formation. Plasma treatment appears to provide a safe and
eﬀective treatment of mesh skin grafted scars.
5. Conclusion
In this study, plasma treatment appears to be safe and
eﬀective for treating mesh skin grafted scars. However,
hypopigmentation is a potential complication of this treat-
ment. Future studies with a larger patient size are needed to
evaluate the safety and eﬀectiveness of this procedure.
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